1. Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis 
John Gubatan, Shuji Mitsuhashi, Talia Zenlea, Laura Rosenberg, Simon Robson, Alan C. Moss 
Clinical Gastroenterology and Hepatology 
Volume 15, Issue 2, Pages e1 (February 2017)
DOI: /j.cgh
Copyright © 2017 AGA Institute Terms and Conditions

2. Figure 1
Distribution of serum vitamin D levels among ulcerative colitis patients by clinical relapse status at 12 months.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

3. Figure 2
Receiver Operating Characteristic (ROC) curve of serum vitamin D levels for the outcome of clinical relapse.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

4. Figure 3
Time to event analysis of the effect of serum vitamin D levels on risk of clinical relapse in ulcerative colitis patients in remission.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions

5. Supplementary Figure 1
Baseline SCCAI among prospective cohort (N = 70). All patients were in clinical remission with SCCAI of 2 or less at time of enrollment.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2017 AGA Institute Terms and Conditions